• Improving early-stage drug discovery

    Supporting drug discovery teams in pharma, biotech and academic organisations, our boutique Discovery Services provide cutting-edge phenotypic insight to help shorten lead times and costs.

    • Fully collaborative services
    • Advanced discovery platform
    • Disease models with human relevance
    • Specialists in CNS and pain disease areas

Latest News

Cellectricon transfers the Dynaflow® Resolve technology to Fluicell AB

Cellectricon has signed a license agreement with Fluicell AB, granting the exclusive right, inter alia, to sell the Dynaflow Resolve technology […]

We are recruiting! Assay Scientist & Laboratory Assistant

Cellectricon continues to grow and we are now looking to fill two positions; an assay development and screening scientist and […]

SfN Poster – Modulation of synaptic transmission using muscarinic and GABA-A receptor ligands in neuronal cultures using a high capacity assay

Date: Nov 11, 2017 Presentation Time: 1:00 pm – 2:00 pm Presentation Number: 039.09 Poster Board Number: D58 Abstract Modulators […]

SfN Poster – Development of a human high throughput neuronal activity assay for chronic pain

Date: Nov 14, 2017 Presentation Time: 9:00 am – 10:00 am Presentation Number: 486.14 Poster Board Number: AA9 Abstract Physiologically […]

SfN Poster – Pharmacological validation of a human, pain-relevant high throughput assay

Date: Nov 15, 2017 Presentation Time: 4:00 pm – 5:00 pm Presentation Number: 767.28 Poster Board Number: AA12 Abstract Progress in […]